On Wednesday, June 3, the Center for Medicare & Medicaid Innovation (CMMI) announced that, in response to the COVID-19 public health emergency (PHE), CMMI is providing new flexibilities and adjustments to current and future Innovation Center models. The announcement included the following changes specifically for Oncology Care Model (OCM).
Payment Methodology:
Quality Reporting:
-Make the following optional for the affected performance periods:
-Remove the requirement for cost and resource utilization reporting and practice transformation plan reporting in July/August 2020.
Timeline:Â Extend model for 1 year through June 2022.
The CMS Innovation Center will host a call on Friday, June 5, 2020, from 2:00 PM – 3:00 PM ET to provide an overview of the Oncology Care Model adjustments and flexibilities and answer your questions.
When: Friday, 06/05/2020 from 2:00 PM – 3:00 PM ET
Register Here.
View information on the CMMI website here.
Read a Health Affairs blog post by CMS Administrator Seema Verma.
Posted 6/3/2020
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
